Patents Assigned to Anaxis Pharma Pty Ltd
  • Sulphonamide compounds
    Patent number: 12583836
    Abstract: This invention relates to compounds of formula (I) and salts, solvates, tautomers, N-oxides, stereoisomers, polymorphs and/or prodrugs thereof. Also disclosed is the use of the compounds of formula (I) to treat necroptosis and/or inhibit MLKL.
    Type: Grant
    Filed: June 18, 2021
    Date of Patent: March 24, 2026
    Assignee: Anaxis Pharma Pty Ltd
    Inventors: Jean-Marc Daniel Garnier, Martin Brzozowski, John Thomas Feutrill, Guillaume Laurent Lessene, Christopher Gardner, Peter Edward Czabotar, Angus Cowan, Katherine Davies, Pooja Sharma, Carole Annie Schuster-Klein, Christophe Poitevin